Clinical Trials Browser

Mesothelioma, Malignant × cemiplimab × 1 year × Clear all

NCT07234058 2026-02-11

LAG-MAPS

Phase 2 Not yet recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant